EDEN PRAIRIE – October 21, 2026 -- Third-party testing laboratory DDL has appointed Amy Miller as Senior Director of Lab Support Services & Scientific Affairs and Bob Anderson as Director of Lab Operations, adding a combined 58 years of industry experience to its GMP testing business.
Miller brings 28 years of analytical and marketing leadership from CDMO and device settings
Miller's background spans global pharmaceutical component and medical device manufacturing, service partnerships and CDMO environments. DDL said her analytical services strategy expertise will help it extend testing services to evolving pharmaceutical packaging and drug delivery needs.
Anderson contributes 30 years in cGMP lab operations and inhalation, transdermal and microneedle testing
Anderson's career covers pharmaceutical product development, analytical chemistry and cGMP laboratory operations. His analytical work has focused on inhalation, transdermal and microneedle delivery platforms, from early-stage development through regulatory submission and post-approval support.
Jennifer Riter, Vice President of Analytical Testing Services at DDL, said the hires strengthen the scientific and operational leadership behind the company's growing GMP laboratory. She said they will help customers facing complex containment, packaging and drug delivery testing challenges.
DDL's FDA-registered Minnetonka lab covers stability, CCIT and distribution testing
DDL runs its GMP testing in an FDA-registered laboratory in Minnetonka, Minnesota, near its Eden Prairie headquarters. The facility handles ICH stability studies, functional and mechanical performance testing, container closure integrity testing (CCIT) and simulated distribution testing. Products tested include auto-injectors, prefilled syringes, inhalers and other drug-device combination products for pharmaceutical, biotech and medical device customers.
DDL described the appointments as building on its investment in GMP testing and pharmaceutical consulting services.